http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CZ-300237-B6
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aaac005693f194c380e291bfc5320c87 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-585 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54313 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 |
| filingDate | 1999-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed77ae59b1cd61a06d90ad82dd197421 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_611e357193e713dc091741cd9272453c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb15a8d2cf3edafc0ed5255003cb6e10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d8bed86c7808f701635054db8145748 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_382a1ddc109d3a3bf55c1f565ced6106 |
| publicationDate | 2009-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CZ-300237-B6 |
| titleOfInvention | Method of evaluating and / or predicting the effect of treatment with specific anti-allergic vaccination |
| abstract | The present invention relates to a method for assessing the immunological status of a subject comprising the step of (1) determining the antibody content of a liquid subject sample using an immunoassay, wherein the reaction between the sample antibody and the antigen, antibody, or hapten ligand, wherein the ligand is directed against the Fab region of the sample antibody, performs in the presence of other sample components to obtain measurement 1, step (2), wherein the antibody content of the liquid sample is determined using an immunoassay, wherein the reaction between the sample antibody and the ligand in the form of antigen, antibody, or hapten, wherein the ligand is directed against the Fab region of the sample antibody is performed in the absence of other sample components to obtain measurement 2, and step (3) in which measurements 1 and 2 are related to express the interaction and the interaction is used as a parameter to evaluate the subject's immunological status. |
| priorityDate | 1998-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 45.